In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
|Videos|January 27, 2017
Gary Shelton on Reimbursement for Palliative Care
Author(s)Gary Shelton, PhD
Advertisement
Gary Shelton, PhD, coordinator of supportive oncology services at NYU Perlmutter Cancer Center, discusses reimbursement for palliative care.
There are codes dedicated for certain palliative services, such as symptom management and discussing advanced directives or goals of care. Insurance companies do often cover these services. Additionally, if a patient is receiving palliative care while seeing another provider, the service can be added on.
Advertisement
Related to this article
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer
2
IMS 2026: Beth Faiman Talks New Definition of Myeloma Cure and More
3
FDA Approves Maintenance Tucatinib for Advanced HER2+ Breast Cancer
4
Daily Symptom Shifts Linked to Quality of Life in Metastatic Breast Cancer
5